Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/26/1991 | US5068338 Process for nitrosamine-free sabilized isothiazolones |
11/26/1991 | US5068337 1,4-dihydropyridines and their ability to inhibit blood platelet aggregation, inhibit thromboxane synthetase and phospholipase |
11/26/1991 | US5068334 Analgesics and antipyretics |
11/26/1991 | US5068333 Aldose reductase inhibitors |
11/26/1991 | US5068332 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
11/26/1991 | US5068325 Dopaminergic systems as hypotensives, sedatives, antitussives and/or antiphlogistics |
11/26/1991 | US5068322 Crystalline cephalosporin compounds |
11/26/1991 | US5068320 2-amino-6-(cyclopropylamino)purine-9-β-D-2',3'-dideoxyribofuranoside and its pharmaceutically acceptable salts |
11/26/1991 | US5068272 Salt with 4-(3-(ethyl-(3-(propylsulfinyl)propyl)amino)-2-hydroxypropoxy)benzonitrile |
11/26/1991 | US5068253 Treatment of a microbial infection with drugs containing para-acetamidobenzoic acid |
11/26/1991 | US5068251 Lipoxygenase inhibiting compounds |
11/26/1991 | US5068249 Histamine H2 antagonist, (N-(2-(((5-(dimethylamino)methyl-2-furanyl)-methyl)thio)ethyl)-N'-methyl-2 -nitro-1,1-ethenediamine |
11/26/1991 | US5068248 Analgesics, antipyretics and antiinflammatory agents |
11/26/1991 | US5068244 Benzocyclohexanes and analgesic compositions thereof |
11/26/1991 | US5068242 Pyrrolidine-2-carboxylic acid derivatives and their use for psychotropic action |
11/26/1991 | US5068240 Antitumor pharmaceutical compositions and process for preparing the same |
11/26/1991 | US5068239 Tetrazoleacetic acid derivatives and use for aldose reductase inhibitory activity |
11/26/1991 | US5068238 Anticonvulsants, schizophrenia, sleep disorders, antiischemia agents and cognition activators |
11/26/1991 | US5068236 Xanthine derivatives |
11/26/1991 | US5068235 Diazabicycloalkane derivative |
11/26/1991 | US5068234 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles |
11/26/1991 | US5068233 Synergistic combination of azelastine and theophylline or azelastine and α-mimetics |
11/26/1991 | US5068232 Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
11/26/1991 | US5068231 Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides |
11/26/1991 | US5068109 Antacid composition |
11/26/1991 | US5068103 Adhesive containing macromolecular substance and sequestering agent spread on support; prevention and treatment of asthma and bronchitis |
11/26/1991 | US5068064 N-substituted lauramides, their preparation and compositions in which they are present |
11/26/1991 | CA2083735A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders |
11/26/1991 | CA2043203A1 Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents |
11/26/1991 | CA2043153A1 Delivery system for cyclic amino acids with improved taste, texture and compressibility |
11/26/1991 | CA2042960A1 Method of inhibiting demineralization of bone |
11/26/1991 | CA2042861A1 Isochromane derivatives |
11/26/1991 | CA1292474C Anti-spasmodic agents having a ring in the main chain |
11/26/1991 | CA1292472C Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
11/26/1991 | CA1292470C 1a 7-substituted derivatives of mitomycin and uses thereof |
11/26/1991 | CA1292468C Nucleosides of 5-monofluoromethyluracil and 5- difluoromethyluracil |
11/26/1991 | CA1292429C Method for controlling parasitoses in bees |
11/25/1991 | WO1991017993A1 1-7 substituted xanthine derivatives having antiasthmatic activity, their salts physiologically acceptable, pharmaceutical composition containing them and process for their preparation |
11/25/1991 | WO1991017750A1 Nicotinylalanine as a therapeutic agent acting on the central nervous system |
11/25/1991 | CA2083507A1 Nicotinylalanine as a therapeutic agent acting on the central nervous system |
11/25/1991 | CA2083257A1 1-7 substituted xanthine derivatives having antiasthmatic activity, their salts physiologically acceptable, pharmaceutical composition containing them and process for their preparation |
11/25/1991 | CA2042931A1 Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines |
11/25/1991 | CA2042545A1 Synthesis of nucleotide and nucleoside derivatives |
11/25/1991 | CA2041950A1 Process for preparing an optically active cyclobutanone, an intermediate in the synthesis of an optically active cyclobutane nucleoside |
11/24/1991 | CA2042944A1 6-substituted purinyl piperazine derivatives |
11/23/1991 | WO1991017977A1 Process for the stereoselective preparation of phenylisoserin derivatives |
11/23/1991 | WO1991017976A1 Process for the enantioselective preparation of phenylisoserin derivatives |
11/23/1991 | WO1991017670A1 Foodstuff with prophylactic and/or curative effect and process for making it |
11/23/1991 | CA2079314A1 Process for the enantioselective preparation of phenylisoserine derivatives |
11/23/1991 | CA2079313A1 Process for the stereoselective preparation of phenylisoserine derivatives |
11/23/1991 | CA2064025A1 Foodstuff with prophylactic and/or curative effect and process for making it |
11/23/1991 | CA2042973A1 Tgf-beta compositions |
11/23/1991 | CA2042904A1 Oxidant sensitive and insensitive aromatic esters as inhibitors or human neutrophil elastase |
11/23/1991 | CA2041379A1 Method of inhibiting human immunodeficiency virus with hydroxychloroquine |
11/22/1991 | WO1991017987A1 Phenol and pyridinol derivatives as pharmaceuticals |
11/22/1991 | WO1991017746A1 The use of phenylpropanolamine as a mucus secretagogue in the upper airways |
11/22/1991 | CA2083403A1 Use of phenylpropanolamine as a mucus secretogogue in the upper airways |
11/22/1991 | CA2081982A1 Phenol and pyridinol derivatives as pharmaceuticals |
11/22/1991 | CA2042982A1 3-¬1-thiazolidinylbutyl-4-piperazinyl|-1h-indazoles, a process for their preparation and their use as medicaments |
11/22/1991 | CA2042905A1 Indole derivatives |
11/21/1991 | EP0457716A1 Naphthalin derivatives |
11/21/1991 | EP0457686A1 Novel aminopiperidine, aminopyrrolidine and aminoperhydroazepine derivatives, process for their preparation and pharmaceutical compositions containing them |
11/21/1991 | EP0457680A1 Derivatives of 1,2,5,6-tetrahydropyridine-3-carboxaldehyde oxime, process for their preparation and their use as medicaments |
11/21/1991 | EP0457671A2 Dipyridamide for the treatment of diseases of the central or peripheral nervous system |
11/21/1991 | EP0457586A1 4-alkylamino-6-(C3-5-hydrocarbyl)thieno [2,3-B] thiopyran-2-sulfonamide-7,7-dioxides |
11/21/1991 | EP0457570A1 Nucleoside-phospholipid conjugate |
11/21/1991 | EP0457539A1 Dietary fiber, its process and physiologically active composition containing the same as an active ingredient |
11/21/1991 | EP0457517A1 Avermectin derivatives with a spacer inserted between the disaccharide and the aglycone useful as antiparastic agents |
11/21/1991 | EP0457514A1 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
11/21/1991 | EP0457438A2 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
11/21/1991 | EP0457381A2 Delta 2-cephem sulphones |
11/21/1991 | EP0457378A2 Hypophosphite-containing cotelomers as antitartar agents |
11/21/1991 | EP0457336A2 Use of mizoribine for the treatment or prevention of multiple sclerosis |
11/21/1991 | EP0457333A2 Topical composition |
11/21/1991 | EP0457331A1 Piperidine derivatives and antiulcer composition containing the same |
11/21/1991 | EP0457326A1 Antiviral agents |
11/21/1991 | EP0457324A1 Heterocyclic-NMDA antagonists |
11/21/1991 | EP0457318A1 Alpha-Oxopyrrolo[2,3-b]indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments |
11/21/1991 | EP0457295A2 Use of a modulator of protein phosphorylation in the treatment of amyloidosis associated with Alzheimer's disease |
11/21/1991 | EP0457250A2 Novel bifunctional linking compounds, conjugates and methods for their production |
11/21/1991 | EP0457243A1 Novel tricyclic compounds |
11/21/1991 | EP0457215A1 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation |
11/21/1991 | EP0457199A1 Substituted 3-Aminosydnonimines, method for their preparation and their use |
11/21/1991 | EP0457196A2 Photodynamic inactivation of viruses in cell-containing compositions |
11/21/1991 | EP0457193A2 The use of squalene, squalane or mixtures thereof for preparing a cooling composition for the local treatment of burns |
11/21/1991 | EP0457163A1 Use of oxyl-aminoacid derivatives as drug for inhibiting the prolyl-hydroxylase |
11/21/1991 | EP0457075A2 Process for the preparation of dust and binderfree, free flowing spray granulates or microgranulates of riboflavin from pure riboflavin |
11/21/1991 | EP0457015A2 Use of substituted 1,2,4-triazinediones in combating parasitical protozoa |
11/21/1991 | EP0456988A2 Use of naproxen as mydriatic agent |
11/21/1991 | EP0456928A1 Pasty dialyzing composition for perfusing artificial kidney systems and process for preparing same |
11/21/1991 | EP0456843A1 Bornyl and isobornyl carboxylic esters of condensed tetrahydroquinoxalines as antiviral agents |
11/21/1991 | EP0456835A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof |
11/21/1991 | EP0456833A1 Immunosuppressant and process for preparing the same |
11/21/1991 | EP0456792A1 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
11/21/1991 | EP0456760A1 Lipoxygenase inhibiting compounds |
11/21/1991 | EP0329691B1 Cardiotonic imidazolylphenylpyrrol-2-ones |
11/21/1991 | EP0325628B1 Agent containing salicylic acid for treating lepidosis |
11/21/1991 | DE4115559A1 Antitumormittel mit verminderter toxizitaet auf der basis von cytostatika und xanthogenaten Anti-tumor agent with reduced toxicity on the basis of cytostatics and xanthates |
11/21/1991 | DE4021084C1 Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant |
11/20/1991 | CN1056305A 4(1h) quinolone derivatives |